- Get in Touch with Us
Last Updated: Apr 25, 2025 | Study Period: 2024-2030
The area of medicine known as dermatology deals with the skin, mucous membranes, hair, and nails. The largest organ and one with many potential abnormalities, the skin is reasonably simple to evaluate but also includes roughly 1500 unique skin diseases and many variants.
With a single capture, Dermatology Imaging System captures the complete skin surface at macro quality resolution. Clinicians can map and track skin illnesses that are dispersed and have pigmented lesions thanks to the fully integrated software.
The Global Dermatology imaging system market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.
The VECTRA WB360 whole body 3D imaging technology, which was created especially for dermatology, takes a single capture of the complete skin surface in macro quality resolution.
Clinicians can map and track pigmented lesions and widespread skin diseases thanks to the fully integrated software. Documenting vitiligo, psoriasis, and pigmented lesions are some more uses.
The capacity to follow lesions over time is improved since every close-up image is linked to a single 3D image. Each tagged lesion has a 3D overview image, close-up photos, searchable attributes, and comments that explain the clinical history.
An accessible, well-organized, and secure picture management system houses all of the close-up and panoramic photos.
The Onassis Foundation has presented Canfield's VECTRA WB360 whole-body imaging system to the "Andreas Syggros" Hospital, making it the first WB360 system to be used in a Greek medical facility.
This technology is regarded as the dermatology and skin oncology of the future since it can provide 3D imaging through 46 stereo-vision pods that can capture images using cross-polarized and non-polarized lighting, producing a single 3D image of the complete body.
| S No | Company Name | Development |
|---|---|---|
| 1 | FotoFinder | The new mobile, handheld 2D-imaging solution for aesthetics, meesma, has been launched by FotoFinder Systems. It provides med spas or clinics with global accessibility, making it possible for anyone to take, view, edit, and compare pictures wherever they are. It offers stunning and reliable photos of aesthetic operations from top to bottom, including injectables, body contouring, and laser treatments, without the need for a cumbersome stand or chinrest. Meesma offers a variety of lighting options to show patients' various skin conditions while seamlessly connecting with iPads or iPhones. This new offering from FotoFinder for aesthetics combines beautiful photographs with a variety of consulting tools in a practical software with cloud storage. |
| 2 | FotoFinder | The ATBM master 4th Generation is a gadget that redefines skin imaging with more intelligence and efficient workflows, according to FotoFinder Systems, which also announces its arrival. It is not simply a tool for taking beautiful pictures. The ATBM master 4th Generation's new features, such as Dashboard, Mole Gallery, and AIMEE, a virtual AI Assistant for the assessment of skin lesions, save significant time thanks to its enhanced functionality and efficiency. Total Body Dermoscopy, psoriasis management, and aesthetic imaging are all revolutionised by this ground-breaking device. |
| S NO | Overview of Development | Development Detailing |
| 1 | Barco announced a new partnership with MediPortal, a producer of healthcare software for its Demetra skin imaging systems division. The collaboration will link MediPortal's Mediris Electronic Health Record (EHR) system and Demetra's skin imaging platform, enabling dermatologists to do skin evaluations in a streamlined manner. | Demetra contributes to better patient care by offering visualisations and insights at the point of care to enhance the clinician's choice of management tactics, diagnoses, therapies, and patient follow-ups. With the use of a secure web platform called Mediris, medical personnel may gather, store, manage, and send a patient's electronic medical record. Through the integration, a clinician will be able to receive Demetra's point-of-care diagnostics device's patient demographics from Mediris and then access the diagnostic imaging through Mediris' EHR platform. Demetra's cooperation and integration with MediPortal's Mediris EHR have been announced. They are eager to continue working with MediPortal because they are a creative and quickly expanding healthcare software developer. Dermatologists' normal workflow will be able to use their imaging and analysis technology due to the integration, which will increase productivity and the user experience overall. Demetra's integration into the Mediris EHR presents a fantastic opportunity for clinical partners to take advantage of both Demetra's cutting-edge technology and the cutting-edge, rapidly expanding EHR. As Demetra continues to innovate in the area of dermoscopic imaging, they look forward to working with them in the future. |
| 1 | Market Segmentation |
| 2 | Scope of the report |
| 3 | Abbreviations |
| 4 | Research Methodology |
| 5 | Executive Summary |
| 6 | Introduction |
| 7 | Insights from Industry stakeholders |
| 8 | Cost breakdown of Product by sub-components and average profit margin |
| 9 | Disruptive innovation in theIndustry |
| 10 | Technology trends in the Industry |
| 11 | Consumer trends in the industry |
| 12 | Recent Production Milestones |
| 13 | Component Manufacturing in US, EU and China |
| 14 | COVID-19 impact on overall market |
| 15 | COVID-19 impact on Production of components |
| 16 | COVID-19 impact on Point of sale |
| 17 | Market Segmentation, Dynamics and Forecast by Geography, 2024-2030 |
| 18 | Market Segmentation, Dynamics and Forecast by Product Type, 2024-2030 |
| 19 | Market Segmentation, Dynamics and Forecast by Application, 2024-2030 |
| 20 | Market Segmentation, Dynamics and Forecast by End use, 2024-2030 |
| 21 | Product installation rate by OEM, 2023 |
| 22 | Incline/Decline in Average B-2-B selling price in past 5 years |
| 23 | Competition from substitute products |
| 24 | Gross margin and average profitability of suppliers |
| 25 | New product development in past 12 months |
| 26 | M&A in past 12 months |
| 27 | Growth strategy of leading players |
| 28 | Market share of vendors, 2023 |
| 29 | Company Profiles |
| 30 | Unmet needs and opportunity for new suppliers |
| 31 | Conclusion |
| 32 | Appendix |
© 2017-2025 Mobility Foresights Pvt Ltd. All rights reserved.